文献速递胃肠外科急腹症与外科感染围术期管理与 ERAS

COVID-19封锁期间急性阑尾炎围术期严重程度:回顾性比较队列研究

Perioperative severity of acute appendicitis during the confinement related to SARS COVID-19: a retrospective comparative cohort.
PubMed 文献 · Surg Endosc · 2024-11-25

该回顾性双中心队列研究纳入法国Nancy-Metz地区634例急诊阑尾切除术成人患者,比较2020年COVID-19封锁期(194例)与2018、2019年同期(440例)的围术期严重程度。COVID期围术期严重程度为33.5% vs 25.9%,差异无统计学意义(p=0.0845),术后抗生素疗程较长(6天 vs 5天,p=0.0410),其余次要结局无显著差异。

要点

  • COVID-19封锁期阑尾炎围术期严重程度数值升高但无统计学意义。
  • 封锁期术后抗生素疗程较非COVID期延长1天(6天 vs 5天,p=0.0410)。
  • 就诊至治疗时间、炎症综合征严重度及术后并发症无显著差异。

核心结论

  • COVID-19大流行导致急性阑尾炎围术期严重程度出现无统计学意义的升高。
  • 尽管面临疫情挑战,法国医疗系统仍维持了外科急诊的有效管理,术后并发症无显著增加。

研究设计与样本

  • 回顾性双中心队列研究,纳入法国Nancy大学医院和Metz地区医院634例急诊阑尾切除术成人患者。
  • 主要结局为围术期严重程度,定义为Gomes评分≥3和/或Clavien-Dindo分级≥3;采用校正ASA评分的逻辑回归分析。

主要发现

  • COVID期围术期严重程度为33.5%,非COVID期为25.9%,差异无统计学意义(p=0.0845)。
  • 就诊至治疗时间、生物炎症综合征严重程度及术后并发症在两组间无显著差异。
  • COVID期术后抗生素疗程长于非COVID期(6天 vs 5天,p=0.0410)。

关键数值与推荐

  • 围术期严重程度定义:Gomes评分≥3和/或Clavien-Dindo分级≥3。
  • COVID期围术期严重程度33.5% vs 非COVID期25.9%(p=0.0845)。
  • 术后抗生素疗程:COVID期6天 vs 非COVID期5天(p=0.0410)。

临床怎么用

  • 疫情封锁期应关注阑尾炎患者围术期严重程度可能升高,但本研究未显示统计学显著差异。
  • 封锁期术后抗生素疗程可能延长,需结合临床评估合理使用。

局限性

  • 回顾性设计可能存在选择偏倚和信息偏倚。
  • 样本来自法国两个中心,结论外推需谨慎。
  • 围术期严重程度差异无统计学意义,需更大样本验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the perioperative severity of acute appendicitis during the COVID-19 pandemic compared to the same periods in 2018 and 2019 in the Nancy-Metz region, France. Acute appendicitis is a common surgical emergency that can lead to severe complications if not treated promptly. The COVID-19 pandemic and subsequent lockdowns resulted in reduced hospital visits, potentially delaying treatment for appendicitis and increasing perioperative severity. METHODS: This retrospective, bicentric cohort study included 634 adult patients who underwent emergency appendectomy at the Nancy University Hospital and Metz Regional Hospital. The study compared patients from the pandemic period (March 17, 2020, to December 14, 2020) with those from the same periods in 2018 and 2019. The primary outcome was perioperative severity, defined by a Gomes score ≥ 3 and/or a Clavien-Dindo classification ≥ 3. Secondary outcomes included time to treatment, severity of biological inflammatory syndrome, postoperative complications, and hospitalization metrics. Logistic regression analyses were performed with adjustments for ASA scores. RESULTS: The study included 194 patients from the COVID-19 cohort and 440 from the non-COVID cohort. The perioperative severity was higher during the COVID period (33.5% vs. 25.9%), though this difference was not statistically significant (p = 0.0845). Secondary outcomes such as time to treatment, severity of the inflammatory syndrome, and postoperative complications did not show significant differences between cohorts. However, the duration of postoperative antibiotic therapy was longer during the COVID period (6 days vs. 5 days, p = 0.0410). CONCLUSION: The COVID-19 pandemic led to a non-significant increase in perioperative severity of acute appendicitis. Despite the challenges posed by the pandemic, the French healthcare system maintained effective management of surgical emergencies, with no significant increase in postoperative complications. Further research is required to explore the broader impact of the pandemic on the management of appendicitis.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Bouziane E, Perez M, Brunaud L, et al. Perioperative severity of acute appendicitis during the confinement related to SARS COVID-19: a retrospective comparative cohort. Surg Endosc. 2024. PMID: 39586880. doi:10.1007/s00464-024-11414-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。